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ABSTRACT

As we enter further into the boom of the biotechnology era, the role that plants play in our
everyday lives continues to grow increasingly more important. This article seeks to
provide a general outline of the protections available on a national, as well as,
international level for new plant varieties produced through both genetic engineering
processes utilized by the biotechnology field, as well as, the "older" methods, such as cross
germination, splicing, etc. that are still successfully being utilized by the general scientific
community. In the broadest sense this article is designed to help those who are unfamiliar
with the protections available for new plant varieties better understand the minimal
protections available in those countries that are signatories of the TRIPS-GATT treaty, as
well as, the more specific systems of protection that are available in Europe, Japan, and
the United States. This article is also designed to emphasize the industrially important
role that securing protections for new plant varieties plays in the world of today, as well
as, the world of tomorrow, on both a monetary, as well as, humanitarian level. As the
advances made in the biotech arena offers new hope in erasing world hunger, sicknesses,
such as AIDS, and pollutants resulting from various industrial processes, I can only hope
that the world will continue to embrace, as well as, reinforce the plant protections that are
currently available.
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MARY MARY QUITE CONTRARY How DOES YOUR BIODIVERSE GARDEN GROW? 1 AN
OVERVIEW OF INTELLECTUAL PROPERTY PROTECTIONS FOR PLANTS IN THE UNITED
STATES, EUROPE, AND JAPAN

JACQUELINE M. COHEN*
Once upon a time Mary Q. Contrary only had to worry about how the plants
sewn in her garden grew. However, the role that plants play in agriculture, health,
and manufacturing has rapidly grown and expanded, 2 and now Ms. Contrary must
decide whether to protect the new plant varieties growing in her garden, or allow the
new varieties to be appropriated and commercialized without remuneration for her
efforts. Contrary Mary does not have time to dawdle. She must act fast.
The increasingly important role that plants play in our society is evidenced by
the large percentage (an estimated 80%) of the world's population that depends on
medicines derived from plants to treat their illnesses, 3 the growing trend to utilize
plant resources instead of petroleum-based stocks as the primary source for
manufacturing industrial materials, 4 and the astounding fact that approximately
90% of the world's dietary needs are met by just 20 cultivated crops. 5 With plant
resources in such high demand, it was only a matter of time before scientists would
6
discover a way to more efficiently and effectively meet the demands of our society.
Little did Watson and Crick know that the biotechnology field they fathered would
7
lead to such a sea of change in the use and development of plants.
Biotechnology has been the primary catalyst for this sea of change because it can
be used to decode a plant's genetic blueprints, thereby enabling scientists to enhance
crop productions with greater speed and accuracy than they previously could through
selective breeding processes. 8 Discoveries that once took years or decades to uncover

* Jacqueline Cohen is an associate with the law firm Potter Anderson & Corroon LLP in
Wilmington, Delaware. She received a J.D. from The John Marshall Law School in June 2001 and
an LLM in Intellectual Property Law in January 2002. She would like to thank Karl Maersch for
continually encouraging her to submit an article to The John Marshall Review of Intellectual
Property Law.
I See Mary Mary, Quite Contrary,availableat http://www.tudorhistory.org/poetry/marymary.html
(last visited Mar. 15, 2003) ("Mary, Mary, quite contrary, How does your garden grow? With silver
bells and cockle shells, and pretty maids all in a row.").
2 People, Plants,and Patents,at http://idre.ca/books/725/chapl.html (last visited Mar. 15, 2003).

3 id.
4 Id.

5 -d.
6 Study released by The National Center for Food and Agricultural Policy in 2002 "found that six
biotech crops planted in the United States,,

soybeans, corn, cotton, pa-aya, squash and canola

produced an additional 4 billion pounds of fod ani fiber on the same acreage imp o-ed farm
income by $1.5 billion and reduced pesticide use by 46 million pounds."

7 See generallyDavid S. Tilford, Saving the Blueprints: The InternationalLegal Regime for Plant
Resources, 30 CASE W. RES. J. INT'L L. 373 (1998) (explaining how science changed farming
techniques). The field of biotechnology was born in 1953 when J.D. Watson and Francis Crick
discovered the double helical structure of deoxyribonucleic acid (DNA). Id. at 397. A DNA molecule
is the molecule containing the hereditary characteristics that a plant or animal passes on from one
generation to the next. Id. at 446 n.151.
8 Id. at 398.
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are now discovered in one generation. 9 Moreover, the ability to map a plant's genetic
code has enabled biochemists to more rapidly determine whether a plant has any
medicinal value. 10
In the agricultural world, scientists are using biotechnology to create
transgenic11 plants that attain three primary goals. 12 First, scientists seek to
increase the value that fresh produce has to consumers by creating plants that have
desirable characteristics, i.e., tastier tomatoes,1 3 potatoes having a longer shelf-life,
etc. 14 Second, scientists are trying to create plants that enable farmers to produce
15
larger crops without changing the conditions under which the plants are grown.
Finally, scientists attempt to increase plant resistance to weeds, insects, disease,
temperature fluctuations, and drought.1 6 Apparently scientists have enjoyed some
success because since 1998 farmers have steadily increased the number of acres sewn
17
with genetically engineered plants.
In the industrial community, attempts are being made to replace petroleum as
the primary raw material used to produce plastic with plastic-producing transgenic
plants; to that end researchers have inserted a gene into mustard plants that makes
plastic. 18 Researchers in the paper-making industry have been utilizing gene
manipulation techniques to try and produce trees that have an increased cellulose
content, the structural fiber used to make paper, while at the same time decreasing
the amount of other components responsible for the pollutants that are produced
when the trees are processed into paper.19
In the healthcare industry, biotechnology has reinvigorated the pharmaceutical
industry's search for new plant-derived medicines. 20 By screening plants found in
9 Id.
10Id.at 426-27.
11A transgenic plant is a plant that has had non-indigenous DNA incorporated into it. See Donna
M. Gitter, Led Astray by the Moral Compass IncorporatingMoralityinto European Union
Biotechnology PatentLaw, 19 BERKELEY J. INT'L L. 1, 43 n.27 (2001).
12 Id.at 5.
13 Plant

Biotechnology Timeline: Learn how technology has boon used to improve the food we grow

andeat,available athttp://www.whybiotech.com/index.asp?id=2157 (last visited Mar. 15, 2003). A
bioengineered tomato having more flavor and a longer shelf life is approved by the FDA for sale in
the United States and marketed under the trademarked name FlavrSavr. Id.
14 Id.
15Id. Scientists use bioengineering techniques to successfully grow tomato plants in the salty soil
that would normally cause their demise; a feat that researchers have unsuccesfully been trying to
accomplish for 100 years via selective breeding processes. See also Kristen Philipkoski, Modified
Tomatoes Hold the Salt, at http://www.wired.com/news/print/0, 1294,45694,00.html (last visited Mar.
15, 2003).
16 Mary Lynn Kupchella, AgrieulturalBiotechnology: Why It Can Save the Environment and
Developing Nations,But May Never Geta Chance, 25 WM. & MARY ENVTL. L. & POL'Y REV. 721,
724 (2001).
17Id. "In 1998, genetically engineered crops accounted for 25% of corn acreage planted in the United
States, 38% of soy bean acreage, and 45% of cotton acreage, for a total of 45 million acres, an
increase of 250% from 1997. In 1999, biotechnology plantings in the U.S. increased to 62 million
acres." Id. Moreover, in 2000 farmers in 13 countries planted 109.2 million acres of land with
bioengineered crops, a 25-fold increase over 1996. PlantBiotoehnology Timeline, supra note 13.
IS Lydia Nenow, To Patentor Not To Patent.*The European Union's New Biotech Directive, 23
Hous. J. INT'L L. 569, 576 (2001).
19Id.
20 Tilford, supra note 7, at 428.
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exotic places like the Brazilian rainforest and the mountains of Kenya,
21
pharmaceutical companies have uncovered new medicines worth millions of dollars.
This comment will provide an overview of plant variety protections available in
Europe, the United States, and Japan. Part I of this comment will provide an
overview of the relevant international treaties, and part II will address the
mechanisms available in Europe, the United States, and Japan to protect plants.

I. PROTECTIONS AVAILABLE FOR NEW PLANT VARIETIES
Under the TRIPS (Trade-Related Intellectual Property) portion of the General
Agreement on Tariffs and Trade (GATT), signatory countries must adopt either a
patent system, or some other sui generis system of protection for new varieties of
plant species. 22 A plant variety right is an intellectual property right in a new strain
of plants that is similar to a patent. 23 This right gives the developer of a new species
24
of plant the exclusive right to exploit her new plant for a limited period of time.
One example of a sui generis system of plant protection is the Plant Breeder's
Rights (also known as Plant Variety Protection (PVP)) system offered by the Union
for the Protection of New Varieties of Plants (UPOV).25 Operating under the
umbrella of the World Intellectual Property Organization (WIPO), UPOV was
originally established in 1961 primarily to protect new kinds of flowers and
ornamentals. 26 This primary objective remains unchanged today, with roses and
27
chrysanthemums being the most commonly protected plant species under UPOV.
Plant Breeders' Rights are rights that the Member Countries of UPOV have
incorporated into their national laws. 28 Once incorporated, the government can grant
an exclusive right to the plant breeder enabling the breeder to exclude others for a
limited time from either making, or commercializing the material from the breeder's
29
protected variety of plant.
There is a 1978 version of UPOV 30 and a 1991 version of UPOV 31 in effect
today. 32 Both versions offer a sui generis system for protecting plants, but the

21

Id. at 428-29.

22
23

People, Plants,and Patents, supra note 2.
Timothy Millett, The Community System ofPlant Variety Rights, 24 EUR. L. REV. 231 (1999).

2

Jd

25

People, Plants,and Patents, supra note 2.

26 Id6
27

Id.

28

Henrique Freire de Oliveira Souza, Genetica-ly Modified Plants:A Need for International

Regulation, 6 ANN. SURV. INTL & COMP. L. 129, 136 (2000).
2) Id. at 135-36.
'0See International Convention for the Protection of New Varieties of Plants, Dec. 12, 1961, as
revised at Geneva on Nov. 10, 1972, and on Oct. 23, 1978, and on Mar. 19, 1991, available at
http://www.upov.int/en/publications/pdf/list publications.pdf (last visited Mar. 15, 2003) [hereinafter
UPOV].
31 See UPOV, as revised at Geneva on March 19, 1991, available at
http://www.upov.int/en/publications/pdf/list-publications.pdf (last visited Mar. 15, 2003).
32 People, Plants,and Patents, supra note 2.
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differences between the two versions are significant. 33 The European Union
34
(hereinafter E.U.), United States, and Japan are all members of the 1991 version.
Although the 1978 version provides more flexibility to signatory countries by
allowing each individual country to select the range of plant species entitled to
protection, 35 the 1991 version allows member states to provide more than one form of
intellectual property protection to new plant varieties, i.e., a new plant variety
36
inventor may be granted both a plant or utility patent and plant variety certificate.
The 1991 version, however, does not allow farmers, unless individual signatories
adopt an exception, to save the seeds of a plant species protected by UPOV from one
growing season for planting in the next, a right that is available under the 1978
version. 37 The minimum term of plant variety protection available under the 1991
version has been extended from 18 years to 25 years for trees and vines, and from 15
years to 20 years for all other species. 38 Moreover, the 1991 version extends plant
variety protection to cover the crops harvested from the protected plant varieties, and
provides an option to extend such protection even further to cover products made
from the harvested crops. 39 Finally, the 1991 version incorporates a provision
extending plant variety protection to varieties essentially derived from the protected
40
variety.

33 Id.

See States Party to the InternationalConvention for the Protection of New Varieties ofPlants,
available at http://www.upov.int/en/publications/gazette/pdf/pub422-24- 10-02.pdf (last visited Mar.

'3

15, 2003).
2. Under the 1978 version of UPOV, the individual
member states define the plant varieties entitled to protection via their national laws, while the
1991 version of UPOV requires members to draft their national laws so as to cover plant varieties of
all species and genera. Id.
'36 Millett, supranote 23, at 233 (explaining that the requirement under the 1961 version of UPOV,
'35People, Plants,and Patents, supra note

which only allowed member states to grant one form of protection for a new variety of plant, was

relaxed in the 1978 version before completely being eliminated in the 1991 version).
'37People, Plants,and Patents, supra note 2.
38 Millett, supranote 23, at 233. The term under the 1978 version remains 18 years for trees and
vines and 15 years for all other plant species. UPOV, supra note 30, art. 8.
3) Millett, supranote 23, at 233 (explaining that such a provision "allows imports of harvests from
protected seeds, [or products made therefrom], to be prevented").
40 Id. (explaining that this provision was introduced into the 1991 version to protect plant breeders
who use conventional breeding methods from losing their exclusive rights because a genetic engineer
introduced a cosmetic change into the new variety just weeks after it was put into the stream of
commerce).
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MECHANISMS AVAILABLE IN THE EUROPEAN UNION, UNITED STATES, AND JAPAN
PROTECT NEW PLANT VARIETIES

To

A. The European Union
There are three primary sources of law governing the protection of new plant
varieties: 1) the European Patent Convention 41 (EPC); 2) plant variety protection
certificates; and 3) the Biotechnology Directive 42 (Biotech Directive).

1. The EuropeanPatent Convention
The EPC was adopted in 1973 by the E.U. members in order to enable an
inventor to obtain patent protection throughout the entire E.U. by filing a single
patent application with a central authority. 43 The central authority administering
the system is the European Patent Office (EPO). Although the grant of a patent by
the EPO instantly creates a bundle of E.U. patents, the enforceability of the patent
that is granted will be governed by the national laws of each individual E.U.
44
member.
Under article 53(b) of the EPC, plant varieties are excluded from patent
protection. 45 Article 53(b) provides in relevant part: "European patents shall not be
granted in respect of: (b) plant or animal varieties or essentially biological processes
for the production of plants or animals; this provision does not apply to
microbiological processes or the products thereof."46 The EPC does not provide
definitions for the terms "essentially biological" or "plant varieties," 47 leading to
uncertainty as to the extent of the prohibition on patenting plant varieties. The EPO
has explained through Board opinions that "essentially biological" means that all
steps which are essential to, and have a decisive impact on the final results of the
claimed process, must be capable of being carried out without any human
48
intervention.
With respect to "plant varieties," the EPO Technical Board of Appeals, in Plant
Genetic Systems/Glutamine Synthetase Inhibitor, construed the term broadly to
include plants that had been genetically modified. 49 As a result, the EPO had to
"suspend its previous practice of granting claims to genetically modified plants." 50
11Convention on the Grant of European Patents, Oct. 5, 1973, 1065 U.N.T.S. 199 [hereinafter EPC].
The members of the EPC are the fifteen E.U. member states, see infra note 57, as well as Cyprus,
Lichtenstein, Monaco, and Switzerland. Gitter, supra note 11, at 43 n.133.
42 Council Directive 98/44/EC on the Legal Protection of Biotechnological Inventions, 1998 O.J. (L
213) 13 [hereinafter Biotech Directive].
43 Nenow, supra note 18, at 583-84.
44 Id. at 584.
45 EPC, supra note 41, art. 53(b).
46

_Td

47 Td.

48 See Nenow, supra note 18, at 587.
4) Decision T356/93, Plant Genetic Systems/Glutamine Synthetase Inhibitors, 1995 E.P.O.R. 357,

375, 380 (1995).
o Tim Roberts, EPOPatents- PatentabilityofPlants, 22 E.I.P.R. N49, N49 (2000).
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Discontent with the decision of the Technical Board of Appeals, Novartis appealed a
test case involving transgenic plants to the EPO Enlarged Board of Appeals. 51 The
Enlarged Board held that plants are not per se excluded from patentability under
article 53(b).52 Although the Enlarged Board held that the definition of a plant
variety does include genetically modified plants, 53 they carved out an exception to the
general prohibition on patenting plants.
The Enlarged Board held that the term "plant varieties" only encompasses
claims drawn to specific plant varieties, and is not applicable to claims that
encompass more than one variety. 54 The Enlarged Board's decision is designed (1) to
prevent patents from being granted for specific plant varieties that can be protected
by plant variety rights, and (2) to enable inventors to obtain patents directed at plant
groupings because such plant groupings cannot be protected by plant variety rights
(PVRs can only protect specific plant varieties). 55 A similar outcome would be
reached under the provisions of the Biotech Directive, which will be discussed further
infra, although the Board did not rely on the Biotech Directive in reaching its
56
decision.

2. Community Plant Variety Rights
In 1995, the European Union, 57 in conformity with the 1991 version of UPOV,
adopted the Community Plant Varieties Rights 58 (hereinafter CPVR). 59 The CPVR
system was adopted in order to enable a plant breeder to file one application and
obtain protection for a new plant variety in the entire territory of the E.U. 60 Prior to
the inception of the CPVR system, plant breeders wishing to obtain protection for a
new plant variety in the entire E.U. territory had to file separate applications to each
6 1
individual member state.
The Community Plant Variety Office (CPVO), located in Angers, France, was
established to administer the CPVR system. 62 The CPVO is required to accept all
51 Id.

52

Jd

5:3Id.

54 Margaret Lewelyn, The PatentabityofBiologicalMaterial:Continuing Contradictionand

Confusion, 22 E.I.P.R. 191, 196 (2000).
5, Roberts, supra note 50, at N49.
56 d
57

The European Union consists of the following member states, all of whom were affected by the

enactment of the Biotechnology Directive: Austria, Belgium, Denmark, Finland, France, Germany,
Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden, & the United Kingdom.
See Gitter, supra note 11, at 43 n.4.
58 Council Regulation 2100/94 of July 27, 1994 on Community Plant Variety Rights, 1994 O.J. (L
227) 1, amended by Council Regulation 2506/94 on Community Plant Variety Rights, 1995 O.J. (L
258) 3 [hereinafter CPVR].
59 Millett, supranote 23, at 234.
60 Certifieateof Community Protectionfor Plant Varieties, at
http://www.sib.it/engsib/nov-veg/cer-euri.htm (last visited Mar. 15, 2003).
6;1B. P. Kiewiet, CPVO Papers,athttp://www.sib.it/engsib/nov-veg/cer-euri.htm (last visited Mar.
15, 2003).
62 Millett, supranote 23, at 244.
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applications and any other papers that are submitted in the official language of any
63
of the E.U. member states.
Under article 5 of the CPVR, a "variety" is defined as a "plant grouping within a
single botanical taxon of the lowest known rank, which grouping can be defined by:
the expression of the characteristics that results from a given genotype or
combination of genotypes, distinguished from any other plant grouping by the
expression of at least one of the said characteristics, and considered as a unit with
regard to its suitability for being propagated unchanged." 64 A "plant grouping" is
further defined by article 5 as "entire plants or parts of plants as far as such parts
' 65
are capable of producing entire plants.
Moreover, a plant breeder will only be granted a CPVR if the variety is: 1)
distinct, 2) uniform, 3) stable, and 4) novel.6 6 A variety isdistinct if, on the date the
application is filed, the variety is different from any other variety then known.67 A
"uniform" variety is a variety that expresses the characteristics making it distinct
with very little variation when propagated.68 A variety is considered "stable" when
the characteristics making it distinct do not change after repeated propagation. 69 A
variety is considered "novel" if the CPVR application is filed within one year of the
variety being commercialized in the E.U. and/or within four years (six years if a tree
0
or vine) of the variety being commercialized outside the E.U.7
In order to obtain a CPVR, the applicant must be a natural or legal citizen or
resident of either an E.U. or UPOV member state, or any other country guaranteeing
reciprocal treatment to legal citizens or residents of E.U. member states.71 The grant
of community-wide protection lasts for 30 years for vine and tree species and 25 years
for all other species.72 These terms may be extended for up to five years for specific
genera and species, and has been extended for potatoes because of their long
breeding process.7 3 The transfer or termination of a certificate of CPVR protection,
74
transfers or terminates all Community-wide rights obtained thereunder.
Under the CPVR system, E.U. members may continue to grant national plant
variety rights.7 5 However, the inventor of a new plant variety may not obtain a
certificate of Community protection and a certificate of national protection in the
76
same variety, the applicant must choose between national and Community rights.

63 Id. at 245. As of May, 2001, the CPVO has received more than 12,600 CPVR applications.

Community Plant Variety Rights and NewAp-rieot Va-rieties, at http://www.cpvo.fr/news/apricot.pdf
(last visited March 15, 2003).
64CPVR, supranote 58, art. 5.
65 Jd
66 CPVR, supranote 58, art. 6.
67 Community Plant Variety Rights and New Aprieot Varieties, supra note 63.
68 CPVR, supranote 58, art. 8.
69 CommunityPlant Variety Rights and New Apricot Varieties, supra note 63.
70_Id
71 Certifieateof Comm unity Protectionfor Plant Varieties, supranote 60.
72CPVR, supranote 58, art. 19.
73 Millett, supra note 23, at 242.
74Id.at 235.
75 Id.

76;
Id.
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Moreover, a plant variety protected under the CPVR system may not be the subject of
any European or national patent."

3. The Biotechnology Directive
On June 16, 1998, the E.U. enacted the Biotechnology Directive, which
came into force on July 30, 1998.78 The Biotech Directive was designed to:
adapt European intellectual property rights to recent technological changes
and to harmonize the domestic laws of the member states with the goal of
creating the legal certainty required to draw the biotech industry into the
European Union, ending the competitive disadvantage that separated the
79
European Union from the United States.
The Biotech Directive required each member state to enact national laws protecting
80
biotechnological inventions by July 30, 2000.81
Article 4.1 of the Biotech Directive, which is a mirror image of article 53(b) of the
EPC, provides that "plant and animal varieties [and] essentially biological processes
for the production of plants or animals" are not patentable. 82
However, this
limitation is qualified by article 4.2 of the Biotech Directive, which provides that
"plants or animals shall be patentable if the technical feasibility of the invention is
not confined to a particular plant or animal variety." 83
The Biotech Directive

Id.
Robin Nott, 'You Did It': The European Biotechnology Directiveat Last, 20 EUR. INTELL. PROP.
REV. 347, 347 (1998). A directive is a law that establishes a specific goal which each member state
must achieve, and although the goal itself is binding on each member state, the members are
permitted to choose the method and, sometimes, the extent to which the announced goal will be
implemented. Gitter, supranote 11, at 43 n.3. A regulation, on the other hand, is a law that not
only establishes a particular goal to be achieved by each member state, but also dictates the method
and extent of its implementation. Id. As a result, directives give member states the flexibility
necessary to harmonize the national laws affected by their enactment. Id.
79 Nenow, supra note 18, at 590.
80 Biotech Directive, supra note 42, art. 1.1.
8I Nott, supra note 78, at 347. However, "[a]s of September 2, 2000, only Denmark, the United
Kingdom, and Austria had amended their national laws in accordance with the Directive." Gitter,
supra note 11, at 43 n.20. On the contrary, the Netherlands, with the support of Italy and Norway,
filed an action in the European Court of Justice seeking to have the Directive annulled,
Biotechnology Patentsin Europe, at http://www.sib.it/engsib/novita/pat/151001.htm (last visited
Mar. 15, 2003), while the German and French lawmakers sought to have the Directive immediately
renegotiated. Gitter, supra note 11, at 43 n.20. On October 9, 2001, the European Court of Justice
ruled against the Netherlands finding that 1) a proper legal basis was used to adopt the Biotech
Directive, 2) the Biotech Directive is not inconsistent with the laws pertaining to patentability of
plants because no conflict is possible between the laws governing plant varieties and patents, and 3)
the Biotech Directive does not impose a threat to human dignity and integrity, which is a general
principle of E.U. law. BioteehnologyPatentsin Europe, supra.
82 Biotech Directive, supra note 42, art. 4.1(a) & (b).
83 Biotech Directive, supra note 42, art. 4.2.
77
78
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introduced this exception to expressly allow claims directed at plant groupings, which
84
cannot be protected by plant variety rights, to be patentable.
Moreover, article 2.3 of the Biotech Directive adopted the definition of "variety"
that is set forth in article 5 of the CPVR 85 (see section IJ.A.2 infra) to eliminate the
uncertainty found in the EPC regarding the definition of a "plant variety." It is also
important to note that the Biotech Directive and EPC operate independently of each
other, with neither superseding the other. 86 As a result, a plant breeder seeking
patent protection for a new plant variety would be well advised to apply directly to
the countries that have adopted laws complying with the Biotech Directive.

B. The United States
Unlike the E.U., the United States does allow a plant breeder to obtain patent
protection for a new plant variety. As a result, a plant breeder seeking protection in
the United States can obtain 1) a plant patent, 2) a utility patent, or 3) plant variety
rights. 87 The laws governing the three options available to plant breeders overlap
and therefore "[any attempt to obtain dual protection may be objected to on a double
patenting grounds....

1. PlantPatent
In 1930 the United States passed the Plant Patent Act to protect asexually
reproduced plants. 89 The Plant Patent Act was established in order to give the
agricultural industry the same opportunity to participate in the patent system that
was offered to other industries.9 0 Under the Plant Patent Act, a plant breeder may
obtain patent protection for an asexually reproduced 91 plant variety that is distinct
and new, and is neither a tuber propagated plant, nor a plant found in an

Llewelyn, supra note 54, at 193. See also Biotech Directive, supra note 42, recital 31 (stating that
"'w]hereas a plant grouping which is characterized by a particular gene (and not its whole genome)
8

is not covered by the protection of new varieties and is therefore not excluded from patentability
even if it comprises new varieties of plants").
85Biotech Directive, supra note 42, art. 2.3.
86 Nott,

supra note 78, at 349 (explaining that the Biotech Directive is not directly applicable to

patents granted by the EPO). See also Gitter, supra note 11, at 43 n.138 ("The governing bodies of

the E.U. do not exercise any control over the EPC, and the EPO is not legally bound to follow the
[Biotech] Directive.").
87 Janice M. Strachan, Plant Vaoriety Protoetion:AnAlternativo to Patents,availablo at
http://www.nal.usda.gov/pgdic/Probe/v2n2/plant.html (last visited Mar. 15, 2003).
5 DONALD S. CHISUM, CHISUM ON PATENTS § 1.05[4], at *33 (2002).
89 Kupchella, supranote 16, at 737. In fact, the United States is believed
88

to be the first country to
incorporate legal provisions for plant patents into their Patent Laws. Soo also 1 SINNOTT, BAXTER
WORLD PATENT LAW & PRACTICE § 1.08 (2001).
90 CHISUM, supra note 88, §1.05 at *1.

§ 1601 (Aug. 2001). Asexual reproduction
involves the propagation of plants by rooting of cuttings, by grafting, budding, layering, inarching
etc., and does not involve the propagation of plants from seeds. Id.
91MANUAL OF PATENTING EXAMINING PROCEDURE
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uncultivated state. 92 A new and distinct plant variety expresses characteristics that
93
distinguish it from other known varieties.
Although the term "plant" was not defined in the Plant Patent Act, the Federal
Circuit's predecessor, the Court of Customs and Patent Appeals explained in In re
ArzbergeA4 that the legislative history surrounding the Act clearly indicated the
term "plant" was being used in its ordinary sense. 95 Accordingly, protection under
the Plant Patent Act only extends to plants in their ordinary and common sense
96
rather than their strict scientific sense.
A plant patent only gives its holder the right to exclude others from 1) asexually
reproducing the plant, 2) selling the asexually reproduced plant, and 3) using the
asexually reproduced plant without the patent holder's permission. 97 Accordingly, a
person who sexually reproduces a plant (that is, with seeds) which is protected under
the Plant Patent Act does not infringe any rights of the plant patent holder. 98 The
Plant Patent Act, therefore effectively excludes all plants from patent protection that
are reproduced from seeds, as well as bacteria, fungi, and tuber propagated plants. 99
In 1998, the Plant Patent Act was amended in order to extend plant patent
protection to cover the "parts" of asexually reproduced plants.10 0 This extension gave
plant patent holders the right to exclude others from using, selling, and importing
"parts" of an asexually reproduced plant.101 However, the amendment is only
applicable to patents issued on or after October 27, 1998.102

2. Utility Patent
Prior to 1980, a utility patent could not be obtained on plants under 35 U.S.C §
101 because it was believed that the patent protections afforded under § 101 did not
extend to living things. 10 3 In 1980, however, the Supreme Court held in Diamond v.
04
Chakrabarty4
that living, genetically-altered
microorganisms constituted
patentable subject matter under Section 101.105 In 1985, the holding in Diamond v.
Chakrabartywas extended by the Board of Patent Appeals and Interferences in Ex

§ 1.05 at *1.
Id.,'see also 35 U.S.C. § 161 (2002) (providing in relevant part: "Whoever invents or discovers and
asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants,
hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an
uncultivated state, may obtain a patent therefore ... .
94 In reArzberger, 112 F.2d 834 (C.C.P.A. 1940).
95 CHISUM, supra note 88, §1.05[1][b][i] at *5.
92 CHISUM, supra note 88,
93

96 Id.
97

Id. at * 1.

98 Id.

9 J.H. Reichman, LegalHybrids Between the Patentand CopyrightParadigms,94 COLUM. L. REV.
2432, 2558 n.155 (1994).
100CHISUM, supra note 88, §1.05[1][d] at *17.
10IId. at *17-18.
102 Id. at "18.
103 Kupchella, supranote 16, at 737.

IM447 U.S. 303 (1980).
105CHISUM, supra note 88, §1.05 at *22.
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06
Parte HibbercP
to include plants, plant seeds, and plant tissue cultures as
constituting patentable subject matter under 35 U.S.C. § 101.107 The United States
Supreme Court's recent decision in JE.M.AG Supply, Inc. v. PioneerHi-Bred Int,
Inc.10 8 dispelled any questions that remained regarding the protectability of sexually
reproduced plants under 35 U.S.C § 101. In J.E.MAG Supply, Inc., the Supreme
Court held that "[niewly developed plant breeds fall within the subject matter of §
101, and neither the PPA [Plant Patent Act] nor the PVPA [Plant Variety Protection
Act] limits the scope of § 101's coverage."10 9 As a result, "the United States offers
perhaps the most comprehensive coverage to biotech inventions of any nation." 110

3. Plant Variety Rights
In 1970, Congress passed the Plant Variety Protection Act (PVPA) in order to
provide protection for the sexually reproduced plants that were expressly excluded
from protection under the Plant Patent Act.111 Congress enacted the PVPA in order
to help the United States remain competitive in the agricultural arena because 1) the
plant breeding technology had evolved from 1930 to 1970 allowing scientists to
"replicate [sexually reproduced varieties] in ways that had previously appeared
impossible" and 2) leading European countries had adopted sui generis systems of
plant protection for new plant varieties. 112 On November 8, 1981, the United States
became a member of UPOV, which required Congress to amend the PVPA in order to
meet the minimum standards established by UPOV. 113 In 1994 Congress once again
amended the PVPA in order to bring it into conformity with the 1991 version of
UPOV.114 However, the amendments made to the 1994 PVPA are applicable only to
certificates that issue on applications filed after the effective date of the changes, and
therefore the provisions of the 1970 PVPA remained applicable to all applications
filed before 1995.115
The PVPA system is administered by the Plant Variety Protection Office (PVPO)
within the Department of Agriculture. 116 In order to be protected under the PVPA,
the plant variety must be new, uniform, stable, and distinct from all other
varieties. 117 Fungi, bacteria, and first generation hybrids are expressly excluded
from protection under the 1970 PVPA.118 However, under the 1994 Act, first-

100227 U.S.P.Q. 443 (1985).
107 CHISUM, sup-ra note 88, §1.05 at *27.
108
'09

No. 99-1996, 2001 U.S. LEXIS 10949, at *1 (Dec. 10, 2001).
Td. at *3.

110 Kupchella, supranote 16, at 737.
111 Reichman, supra note 99, at 2467.
112 Id.

113 CHISUM, supra note

]
"1

88, at *2.

Id.

115 Id. at *19.
116 Reichman, supra note 99, at 2468. The PVPA Office accepts approximately 270 applications per
year and over 2,700 Certificates of Protection have been issued in over 100 crops by the PVPA Office
since 1971. Strachan, supra note 87.
117 Strachan, supra note 87.
118

Id.
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generation hybrids and tuber propagated varieties are eligible for PVPA
protection. 119
A variety is considered new if the variety has not been sold, used, or otherwise
exploited in the United States more than 1 year prior, or in a foreign country more
than 4 years (6 years in the case of a tree or vine) prior, to filing an application for
protection in the United States. 120 A variety is distinct if it is "clearly distinguishable
from any other variety" which is known at the time of filing. 121 A variety is uniform
122
when "any variations are describable, predictable, and commercially acceptable."'
A stable variety is one that remains "unchanged with regard to the essential and
distinctive characteristics of the variety with a reasonable degree of reliability" when
123
reproduced.
A Certificate of Protection remains enforceable for 18 years from the date of
issuance, if governed by the 1970 Act, and 20 years (25 years for trees and vines) if
governed by the 1994 Act. 124 There are two exceptions to a Certificate holder's rights.
First, under the PVPA, farmers are allowed to save seeds from one planting year to
the next either for use on their own farms, or to sell to their neighbors. 125 Second,
scientists are allowed to conduct research using protected varieties without the
Certificate holder's permission in order to promote the free exchange of germplasm
126
within the scientific community.
Unlike patents, the United States does not have to issue a Certificate of
Protection to a foreign national unless a treaty requires them to do S0.127 If there is
no treaty, the United States is only required to offer as much protection in the United
States as the country where the foreign national is domiciled offers to nationals of
128
the United States for the same plant genus and species.

C. Japan
Unlike the European Union and the United States, Japan does not have a plant
variety rights system, opting instead to offer only patent protection for new plant
varieties under their national patent laws.1 29
In 1981, Japan's Ministry of
International Trade and Industry (MITI) recognized biotechnology as the key to the
future success of Japan's industrial technology. 130 At that time, large Japanese
biotechnology corporations were either acquiring, or licensing the technology of
smaller U.S. and European biotechnology companies because Japan's own
119CHISUM,supra note 88, at *20.
120 7 U.S.C. § 2402(a)(1)(A)(B)(i)(ii)

(2001).
§ 2402(a)(2).
122 Id. § 2402(a)(3).
123 Id. § 2402(a)(4).
121 CHISUM, supra note 88, at "18, 29.
125 Strachan, supra note 87.
121 Id.

126 Id.
127 CHISUM,supra note 88, at *19.
128 Id.
129 See Outline ofIndustrialPropertySystems,

athttp://www.jpo.go.jp (last visited Mar. 15, 2003).

See also 2A SINNOTT, BAXTER WORLD PATENT LAW & PRACTICE § APP 1.00, app. 1-4 (2001).
1:30Michael North, The US. Expansion ofPatentableSubject Matter: Creatinga Competitive
Advantage for ForeignMultinationalCompanies, 18 B.U. INT'L L.J. 111, 125 (2000).
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biotechnology research and development efforts were very weak.13 1 MITI was able to
recognize that "the Japanese do not excel in the basic science research that remains
so important to biotechnology," and enacted patent laws that would help strengthen
and maintain the relationship between the large Japanese biotech corporations and
13 2
the smaller foreign biotech companies.
The Japanese Patent Office requirements for patenting living matter are
similar to the requirements of the United States Patent Office.1 3 3 The primary
difference is the refusal of the Japanese Patent Office to grant patents on "processes
in the fields of medicine, diagnosis, therapy, and pharmacology in which the human
body is an indispensable element." 13 4 This difference has resulted in the exclusion of
certain biotechnology inventions that are patentable in the U.S. from being
patentable in Japan. 135 As a result, some U.S. patented inventions may have to be
13 6
changed in order to come within the scope of Japanese patentable subject matter.
Plant patents are specifically addressed by the Japanese patent laws in Chapter
2, "Biological Inventions," of the "Implementing Guidelines for Inventions in Specific
Fields." 13 7 Section 3 of Chapter 2 deals with inventions of plants that relate to parts
of plants, i.e., fruits, uses of plants, processes for creating plants, etc. 138 Section 3
does not pertain either 1) to undifferentiated plant cells, or plant tissue cultures
(these inventions are addressed in Section 2 of Chapter 2), or 2) to matters involving
plants that are related to genetic engineering (these inventions are addressed by
Section 1 of Chapter 2).139
"In an application for the plant itself, the plant must be specifically defined in
the claims." 140 If the application relates to a method for producing the plant, the
claims must sequentially set forth the steps for producing the plant in a clear and
succinct manner. 14 1 Additionally, if one of the steps used to produce the plant
involves a selection based on characteristics, the characteristics necessary for the
selection, as well as any environmental characteristics necessary and indispensable
for the method of production must be disclosed. 142 In sum, all elements that relate to
1)the kind of plant produced, 2) the gene or special property which characterizes the
produced plant, 3) the process for producing the plant, or 4) conditions needed for
cultivation must be disclosed. 143 Moreover, in order for a new plant variety to be
patentable, a person of ordinary skill in the art must be able to achieve the same
plant variety that is disclosed in the patent when the claimed plant is repeatedly
bred.144
131

Id.

132 Id.
133 Id.
131Id. at 125-26.

Id.at 126.
Id.
137 Implementing Guidelinesfor Inventions in Specific Fields, Ch. 2, athttp://www.jpo.go.jp (last
visited Mar. 15, 2003).
1:38Id. at § 3.
135
136

139 Id.

'>0 Akira Kukimoto, PatentLaw, 25 J. OF THE JAPANESE GROUP OF A.I.P.P.I. 170, 179 (2000).
H, Jd.
142

Id.

I 13

Id.

144

Id.
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III. CONCLUSION
As the role that plants play in our everyday lives becomes increasingly more
important, the controversy over how to best protect plant resources will continue to
be forced into the forefront. Regardless of the inevitable controversies lying ahead,
one thing is certain, with biotechnology breakthroughs fueling the rapid discovery of
new plant varieties, the E.U. must either increase the rate at which its laws are
evolving to accommodate these biotech breakthroughs, or continue to lose big biotech
business and their fortunes to the United States and Japan. Although the Biotech
Directive and recent ruling by the EPO Board are steps in the right direction, there
is still too much uncertainty in E.U. law regarding how the Biotech Directive and
EPC laws will be harmonized and interpreted to enable the E.U. to successfully
induce the billion dollar biotech industry to sew their resources in the fields of the
E.U.

